Awake Prone Decubitus Positioning in COVID-19 Patients: A Systematic Review and MetaAnalysis
, e
08 mag 2023
INFORMAZIONI SU QUESTO ARTICOLO
Categoria dell'articolo: Review
Pubblicato online: 08 mag 2023
Pagine: 73 - 86
Ricevuto: 01 mar 2023
Accettato: 26 apr 2023
DOI: https://doi.org/10.2478/jccm-2023-0014
Parole chiave
© 2023 Agustin García et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Fig. 1.

Fig. 2.

Fig. 3.

Characteristics of the Studies and Patients included_
Reference ID, study, and year | Country | Study design | Rating scales (NOS for observational studies and Jadad scale for RCTs) | Total N | Pronated N/nonpronated N | Setting | Age | Male n (%) | Mean BMI (kg/m2) ± SD or median (IQR) or n (%) | Median APACHE II score (IQR) or mean ±SD | Medium SOFA score (IQR) | Oxygen therapy interface |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 DueñasCastell et al., 2021 (42) | Colombia | Retrospective cohort study | 8 | 212 | 212 | GW, ER, or ICU | 63 (median) IQR: 48.873 | 142 (67%) | BMI >30: 11/212 (n/N) (5.2%) | Overall: 4 (35.25) | NC or VMK with a reservoir | |
2 Kaur et al., 2021 (37) | USA | RCT | 3 | 125 | 125 Premature pronation: 92 Delayed pronation: 33 | 62 (mean) ± 11.9 (SD) | 79 (63.2%) | 30 (mean) ± 5 (SD) | Overall: 3 (24.5) | HFNC | ||
3 Ehrmann et al., 2021 (46) | Canada, France, Ireland, Mexico, USA, and Spain | RCT | 3 | 1121 | 564/557 | GW, ER, IMCU, or ICU | 61.1 (mean) | 746 (66.5%) | 29.7 (mean) ±4.6 (SD) Int.: 29.7 ±4.6 Con.: 29.7 ±4.6 | HFNC or NIMV | ||
4 PerezNieto et al., 2021 (43) | Mexico and Ecuador | Retrospective cohort study | 7 | 827 | 505/322 | GW, ER, or ICU | 54.3 (mean) ± 14.2 (SD) | 600 (72.6%) | BMI >30: 119 (14.4%) |
NC, HFNC, or VMK with reservoir | ||
5 Tonelli et al., 2021 (32) | Italy | Retrospective cohort study | 7 | 114 | 38/76 | Respiratory ICU | 67 (median) IQR: 3280 | 80 (70%) | 27.5 (median) IQR: 1937 Int.: 26 (1936) Con.: 28 (2037) | Overall: 10 (422) Int.: 11 (422) Con.: 10 (420) | Overall: 4 (27) Int.: 4 (27) Con.: 4 (26) | NIMV, HFNC, and CPAP |
6 Jayakumar et al., 2021 (45) | India | RCT | 3 | 60 | 30/30 | ICU | 56.05 (mean) | 50 (83.3%) | 27 (mean) Int.: 28.2 ±5.7 Con.: 25.8 ± 2.6 | Int.: 9.5 ±3.6 Con.:8.6±3.1 | NC, MV, VMK with reservoir, HFNC, or NIMV | |
7 Downing et al., 2021 (38) | USA | Retrospective cohort study | 8 | 97 | 97 | GW, ER, or ICU | 54 (mean) ± 14 (SD) | 60 (61.8%) | 31 (mean) BMI <30: 41 (42%) BMI 3040: 37 (38%) BMI >40: 19 (19%) | NC, HFNC, or NIMV | ||
8 Cherian et al., 2021 (39) | USA | Retrospective cohort study | 6 | 59 | 59 | IMCU or ICU | 54.5 (median) | 39 (66%) | BMI <30: 22 (37.2%) BMI >30: 37 (62.7%) | HFNC or NIMV | ||
9 Rosen et al., 2021 (33) | Sweden | RCT | 3 | 75 | 36/39 | 65.48 (median) | 55 (73.3%) | 28.52 (median) | Int.: 28 (2530) Con.: 29 (2733) | HFNC or NIMV | ||
10 Ferrando et al., 2020 (34) | Spain | Prospective cohort study | 8 | 199 | 55/144 | ICU | 62.17 (median) | 147 (73.8%) | 27.16 (median) Int.: 26.8 (24.831.2)/49 Con.: 27.3 (25.129.4)/120 | Int.: 8.5 (613) /46 Con.: 11(814) /107 | Int.:4(44)/46 Con.: 4 (45) /116 | HFNC |
11 Padrao et al., 2020 (44) | Brazil | Retrospective cohort study | 7 | 166 | 57/109 | ER | 58.1 (mean) ± 14.1 (SD) | 112 (67%) | BMI >30: 89 (54%) |
NC, MV, or VMK with reservoir | ||
12 Coppo et al., 2020 (35) | Italy | Prospective cohort study | 7 | 56 | 46 | GW, ER, or HDU | 57.4 (mean) ± 7.4 (SD) | 44 (79%) | 27.5 (mean) ±3.7 (SD) | CPAP, VM, or VMK with reservoir | ||
13 Jagan et al., 2020 (40) | USA | Retrospective cohort study | 7 | 105 | 40/65 | 62.06 (mean) | 57 (54.2%) | 29.25 (median) Int.: 31.3 (26.437.5) Con.: 28 (24.934.4) | Int.: 7 (49) Con.: 10 (716) | Int.: 2 (23) Con.: 4 (25) | ||
14 Prud’homme et al., 2021 (36) | France | Retrospective cohort study | 8 | 96 | 48/48 | Outside the ICU | 61.5 (mean) | 68 (70.8%) | 27.5 (mean) Int.: 27 ±5 Con.: 28 ±5 | NC or HFNC | ||
15 Nauka et al., 2021 (41) | USA | Retrospective casecontrol study | 6 | 600 | 164 | ICU | 61.2 (mean) ± 13.1 (SD) | 372 (62%) | 29.3 (median) IQR: 25.833.9 | Overall: 1 (04) | NC, VMK with reservoir, or HFNC |
Oxygenation Characteristics
Reference ID, study, and year | Initial PaO2/FiO2 ratio | Final PaO2/FiO2 ratio | Initial SpO2/FiO2 ratio | Final SpO2/FiO2 ratio | Initial SpO2 (%) | Final SpO2 (%) | Initial PaO2(mmHg) | Final PaO2(mmHg) | Initial ROX index (points) | Final ROX index | % of responders |
---|---|---|---|---|---|---|---|---|---|---|---|
1. DueñasCastell et al., 2021 | Survivors: 201.1 Nonsurvivors: 134.1 | Survivors: 252.6 Nonsurvivors: 172.4 | Overall: 92 (8896) Survivors: 94 (9097) Nonsurvivors: 88 (8092) | Overall: 96 (9298)Survivors: 97 (9599) Nonsurvivors: 91 (8595) | Overall: 5.12 (4.17.25) Survivors: 5.7 (4.7510.2) Nonsurvivors: 4.1 (3.034.6) | ||||||
2. Kaur et al., 2021 | Premature pronation: 147.98 Delayed pronation: 134.57 | Premature pronation: 163.2 (IQR: 132.8211) Delayed pronation: 141.4 (IQR: 105172.5) | Premature pronation: 5.98 Delayed pronation: 4.79 | Premature pronation: 7.24 (59.93) Delayed pronation: 5 (3.86.95) | |||||||
3. Ehrmann et al., 2021 | PP: 147.9 (SD 43.9) SC: 148.6 (SD 43.1) | ||||||||||
4. PerezNieto et al., 2021 | Overall: 189.5 (SD 81.6) PP: 182.39 (SD 81.91) SC: 201.1 (SD 89.8) | PP: 217.42 (SD 81.9) | |||||||||
5. Tonelli et al., 2021 | Overall: 149 (78272) PP: 141 (73223) SC: 153 (84232) | ||||||||||
6. Jayakumar et al., 2021 | PP: 201.4 ± 118.8 SC: 185.6 ± 126.1 | P/F ratio after 2 hours: PP: 198.5 ± 87.6 SC: 171.7 ± 100.6 | |||||||||
7. Downing et al., 2021 | Intubated (median): 180 IQR: 96, 238) Not intubated: 286 (IQR 221, 329) | After 24 h (median): Intubated: 109 (IQR 73, 174) Not intubated: 255 (IQR 280, 363) | Intubated: 9.9 (IQR 4, 13.5) Not intubated: 15.9 (IQR 11.5, 20.4 | After 24 hours: Intubated: 4.6 (IQR 3.0, 7.9) Not intubated: 15.7 (IQR 8.2, 18.5) | |||||||
8. Cherian et al., 2021 | Overall: 164.6 Intubated: 100 (95155) Nonintubated: 206 (100293) | Four hours after the pronation: Overall: 157.5 Intubated: 99 (94141) Nonintubated: | Overall: 6.44 Intubated:4 (36) Not intubated: 8 (410) | Overall: 6.44 Intubated: 4 (36) Not intubated: 8 (413) | |||||||
9. Rosén et al., 2021 | Overall: 115.51 PP: 115.51 (86.25130.5) SC: 115.51 (93.75129.76) | Overall: 154.1 PP: 151 (131174) SC: 157 (136175) | Overall: 93.52 PP 93 (9194) SC: 94 (9295) | Overall: 67.5 PP 66 (57.7572.75) SC: 69 (61.575) | |||||||
10. Ferrando et al., 2020 | Overall: 114.8 PP: 125 (99187) SC: 111 (83144) | Overall: 95.54 PP: 103 (80125) SC: 92.5 (77125.5) | Overall: 90 PP: 90 (8892) SC: 90 (8894) | Overall: 88.72 PP: 88 (8490) SC: 89 (8692) | |||||||
11. Padrao et al., 2020 | SpO2/FiO2, median (P25, P75): PP: 196 (128, 254) | Median (P25, P75): PP: 224 (159, 307) | Median (P25, P75): Overall: 92.5 (90, 94) PP: 92 (88, 93) SC: 93 (91, 95) | Median (P25, P75): PP: 94 (92, 96) | Median (P25, P75): PP: 5.7 (3.9, 7.7) | Median (P25, P75): PP: 7.7 (5.4, 11) | 10% increase in the SpO2/FiO2: same/51 (51%) 10% decrease in the RR: 35/51 (69%) Either: 41/51 (80%) | ||||
12. Coppo et al., 2020 | SP1 (before pronation): 180.5 (76.6) | SP1: 97.2% (2.0) | PP1: 98.2% (2.2) SP2: 97.1%(2.0) | SP1: 117.1 (47.4) | Increase in the PaO2/FiO2 of SP1 to SP2 23 patients responded to pronation (50%) | ||||||
14. Prud’homme et al., 2021 | Overall: 289 PP: 279+/84 SC: 299 +/45 | ||||||||||
15. Nauka et al., 2021 | Worse prior to pronation: Cases: 93 (9197) Controls: 98 (95294) | Worse after pronation: Cases: 93 (8996) Controls: 97 (95104) |